Biozenta is the vertically integrated, one of the leading & fastest growing pharmaceutical & life sciences group of companies with its presence in various therapies like Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Contrast Media Injectables, Oral Solids - Tablets & Capsules – including Ant-retrovirals (ARVs), External Preparations – Derma & Cosmetics & also vertically integrated for key Oncology Active Pharmaceutical Ingredients (API’s).
Biozenta, a very versatile, fast growing & dynamic organization, established in the year 2018 with a major emphasis to serve the humanity through quality medicines to live the vision “Human helping Human”
Firm believer in Research & Innovation, Biozenta has focused on very unique & innovative products in across the healthcare range. With the state-of-the-art multi-locational EU-GMP approvable facilities, WHO GMP & PICs approved, located in one of the strategic Pharmaceutical Industrial zone of UNA District of H.P., having ultra-modern & well-equipped infrastructure for various units as below:
First
Milestone
Biozenta registered its company in Roorkee, Uttarakhand.
Second
Milestone
Started its Oncology and Critical Care manufacturing Unit at UNA, H.P.
Third
Milestone
Started manufacturing unit for General range Plant for Injectables, Lyophilized Injectables, PFS, Contrast Media and Oral Solids at UNA H.P.
Fourth
Milestone
Established, "Biogracea Medicare", a c-GMP compliant manufacturing unit for “External Preparation Drugs and Cosmetics” at UNA, H. P.
Fifth
Milestone
Started its unique RandD Lab with advanced technology for “MAB-development” (Monoclonal antibody) in Chandigarh.
Sixth
Milestone
Started its corporate office at Mohali Punjab for Business Development Activities and Regulatory Support.
Seventh
Milestone
Proudly received “PICs” approval for Oncology and General Range manufacturing Unit based at UNA, H.P.
Eighth
Milestone
Inaugurated its new “Corporate office” as “Biozenta House” in Mumbai.
Ninth
Milestone
Signed “Partnership deed with US partner for Biosimilar products” to be launched by 2024.
Tenth
Milestone
Launching into the Domestic Marketing Division" at Mohali, 2023.
Eleventh
Milestone
Inaugurated its new “Corporate office” as “Biozenta, USA”